News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement

Thomas Ogorka

Advertisement

Articles by Thomas Ogorka

peer review logo-New-1523372987263.jpg

The Impetus for Natural History Studies in Rare Disease R&D

ByThomas Ogorka,Gajendra Chanchu
April 1st 2018

The use of natural history (NH) studies early in clinical research can help facilitate development programs for orphan drugs.

peer review logo.jpg

Researchers Conduct NH Studies for Rare Diseases and Drug Development

ByThomas Ogorka,Gajendra Chanchu
October 16th 2017

The use of Natural History studies in order to examine a rare disease that will help facilitate drug development programs.

Advertisement

Latest Updated Articles

  • peer review logo.jpg
    Researchers Conduct NH Studies for Rare Diseases and Drug Development

    Published: October 16th 2017 | Updated:

  • peer review logo-New-1523372987263.jpg
    The Impetus for Natural History Studies in Rare Disease R&D

    Published: April 1st 2018 | Updated:



Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal

2

Securing Comparator Drugs in Competitive EU Markets: Challenges and Practical Solutions

3

Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial

4

ACT Brief: Rethinking Representation in Cancer Trials, Positive Phase IIb SLE Data, and a Major Obesity Drug Partnership

5

ACT Brief: EU Comparator Drug Sourcing Pressures, AI Expands Its Role in Oncology Trials, and Rethinking AI Value in Clinical Development

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us